tm logo
GLENMARK GENERICS INC., USA
Dead/Cancelled
CANCELLED - SECTION 8

section 8

on 21 Jan 2022

Last Applicant/ Owned by

750 CORPORATE DRIVE

MAHWAH

NJ

07430

Serial Number

77401451 filed on 20th Feb 2008

Registration Number

3998465 registered on 19th Jul 2011

in the Principal Register

Correspondent Address

Hany W. Rizkalla

GLENMARK PHARMACEUTICALS INC., USA

Legal Department

750 Corporate Dr.

MAHWAH NJ 07430

Filing Basis

1. intent to use

2. use application currently

Disclaimer

"GENERICS INC., USA"

GLENMARK GENERICS INC., USA

GLEN MARK GENERICS INC., USA Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatmRead More

Classification Information


Class [005]
Pharmaceutical Products


Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Preparation for the relief of pain; Opium alkaloid preparations; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations


First Use Date in General

01st Apr 2008

First Use Date in Commerce

01st Apr 2008

Mark Details


Serial Number

No 77401451

Mark Type

No Service/Collective Mark

Attorney Docket Number

No GGI

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
21st Jan 2022CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
19th Jul 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
05th Sep 2017NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
05th Sep 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED
23rd Aug 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
14th Jul 2017TEAS SECTION 8 RECEIVED
19th Jul 2011REGISTERED-PRINCIPAL REGISTER
16th Jun 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
15th Jun 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
10th Jun 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED